Drug Device Combination Products Market To Value US$115 bn By 2019

A new market research report has been recently published by Transparency Market Research and
has been made available for sale on the company website. The research report, titled “Drug Device
Combination Products Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 - 2019,” presents an in-depth analysis of the global drug device combination
products market based on various parameters such as market overview, market drivers, restraints,
challenges and opportunities, product segmentation, and vendor analysis.
According to the research study, in 2012, the global drug device combination products market was
worth US$66 bn and is anticipated to reach US$115 bn by the end of 2019, exhibiting a 7.9%
CAGR between 2013 and 2019. The research report has made use of graphics, tables, and charts to
present the historical data as well as forecast figures of the market. The report has also included
inputs and recommendations from industry experts to help the existing as well as new players in
designing their business strategies.
Read Report Overview @ https://www.transparencymarketresearch.com/drug-devicecombination.html
The global market for drug device combination products is anticipated to grow substantially
throughout the forecast period due to various factors such as government and NGO initiatives for
encouraging drug delivery implants, increasing demand for minimally invasive surgeries, and rising
number of interventional cardiologists. Moreover, advanced technologies, such as implants with
drugs, help in pain relief, lowering morbidity, and quicker healing. Hence, these are anticipated to
fuel the global drug device combination products market in the forecast period. On the other hand,
recall of products due to their severe side effects is one of the major factors that is projected to
hamper the growth of this market in the next few years.
According to type, the global market for drug device combination products is divided into
transdermal patches, drug eluting stents, inhalers, orthopedic combination products, infusion
pumps, photosensitizers, wound care combination products, and other products. A detailed analysis
of the different types of drug device combination products has been included in the report coupled
with their individual market share and revenue for the forecast period from 2013 to 2019.
Geographically, the global market for drug device combination products market has been
segmented into North America, Europe, Asia Pacific, and Rest of the World. Among these regions,
in terms of revenue, the global drug device combination products market is led by North America.
Nevertheless, Asia Pacific is expected to witness high growth due to the growing prevalence of
diabetes, cardiovascular diseases, and obesity, making it the most lucrative market in the coming
years.
The research report has further presented the competitive landscape of the global drug device
combination products market. The vendor analysis includes company details, contact information,
business strategies, financial overview, SWOT analysis, and the recent developments. Some of the
prominent players operating in global drug device combination products market are Pinnacle
Biologics, Inc., W. L. Gore & Associates, Inc., Ethicon, Inc., Stryker Corporation, C.R. Bard, Inc.,
CareFusion Corporation, Medline Industries, Inc., Covidien PLC, Mylan, Inc., Terumo Corporation,
and Medtronic, Inc.
Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=1534
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business
information reports and services. The company’s exclusive blend of quantitative forecasting and
trend analysis provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use proprietary data sources and various
tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it
always reflects the latest trends and information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Moreover, these products offer several advantages which include reduced adverse side effects, improved patient compliance, controlled release administration of drug, and also provide targeted drug delivery. The major product types in the market include drug eluting stents, infusion pumps, photosensitizers, orthopedic combination products, wound care combination products, inhalers, transdermal patches and others which include intraocular implants and drug eluting beads.